Skip To Main Content

For more than 40 years, Genentech has been following the science and seeking solutions to unmet medical needs. As a proud member of the Roche Group, Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening conditions. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. The company has headquarters in South San Francisco, California. For additional information about the company, please visit